Viloxazine: A Nonstimulant Treatment Option for ADHD
Researchers compare viloxazine as a nonstimulant treatment option to atomoxetine for managing inattention, hyperactivity, and impulsivity in pediatric and adult patients with ADHD.
Diagnosis & Disease Information
Brain Fitness Program May Benefit ADHD, Concussion, and Memory Loss
Researchers evaluated the benefits of a multimodal 12-week “brain fitness program” for individuals with ADHD, concussion, and memory loss.
Family History, Psychiatric Comorbidities Predict Tic Disorder Persistence Into Adulthood
Researchers sought to estimate the percentage of tic disorders in childhood that continued into adulthood, as well as the risk factors associated with tic disorder persistence.
ADHD and Short Stature: Evaluating the Link
Researchers from Sweden compared the height of men with and without ADHD before and after ADHD medication availability.
Concerns Over Nonmedical Use of Prescription Stimulants Prompts Labeling Updates
Health care providers are being advised to counsel patients not to share their medications.
A Fifth of Young Patients With ADHD Take Tolerance Breaks From Their Medication
Investigators surveyed adolescents and young adults with self-reported ADHD to determine what proportion already engage in tolerance breaks from their medication, and how often.
ADHD in Teenagers: Age of Stimulant Medication Initiation, Duration May Impact Drug Misuse
Investigators assessed the impact of age at initiation of prescription stimulant medication and duration of stimulant therapy in adolescents with ADHD on rates of misuse of prescription stimulants, methamphetamine, or cocaine.
Pediatric Mental Disorder Risk Associated With Gender, Family Income, Obesity
This study was designed to be a current snapshot of the prevalence of and trends in mental disorders among children aged 9 to 10 years in the US.
In ADHD, Adhering to Physical Activity, Sleep Recommendations Decreases Risk for Cognitive, Social Difficulties
This study looked at whether youth with ADHD following 24-HMB recommendations were less likely to have difficulty concentrating, remembering, or making decisions and making or keeping friends.
Update on the Shortage of Amphetamine Mixed Salts for ADHD
In October 2022, the US Food and Drug Administration announced a shortage of the immediate release formulation of amphetamine mixed salts.
- Loading...
Loading...
Loading... 
Loading...